Acute Agitation and Aggression Treatment Market Size, Share, Growth and Report 2024-2031

Acute Agitation and Aggression Treatment Market is expected to grow at a CAGR of 5% during the forecast period (2024-2031).

Agitation is defined as excessive verbal or motor behavior in an individual, which can escalate into aggression, either verbal or physical. Various treatment options are available to manage acute agitation and aggression, including environmental de-escalation techniques, biological treatments, non-pharmacologic behavioral therapies like electroconvulsive therapy, and pharmacologic agents. Factors such as the growing prevalence of acute agitation and aggression due to workplace stress and the rising burden of mental illness are expected to drive market growth. Additionally, government awareness programs and the increasing incidence of dementia among the elderly population are further contributing to the market's expansion globally.

Get a Free Sample Research PDF - https://www.datamintelligence.com/download-sample/acute-agitation-and-aggression-treatment-market

Market Dynamics:

An increase in the incidence of dementia in the geriatric population continues supporting the market's growth during the forecast period.

Dementia and depression are among the most common mental and neurological disorders globally, with dementia affecting around 5% and depression impacting nearly 7% of the elderly population. Ongoing clinical trials are exploring the use of certain agents to treat agitation associated with Alzheimer's-type dementia and PTSD. Adults tend to overcome the social stigma surrounding mental health treatment more than the elderly, and they are more likely to seek diagnosis and treatment for mental disorders. Increasing workplace stress is another significant factor contributing to the growth of the global market for treatments of acute agitation and aggression. Workplace stress can stem from various sources or a single event, affecting both employees and employers.

According to the National Institute of Mental Health, in 2020, approximately 52.9 million U.S. adults aged 18 or older experienced any mental illness (AMI), representing 21.0% of the adult population. The prevalence of AMI was higher in females (25.8%) than males (15.8%). Young adults aged 18-25 had the highest rate of AMI (30.6%), followed by those aged 26-49 (25.3%) and those 50 or older (14.5%). Stress levels have also risen significantly in the U.S., with job-related stress being a primary contributor. According to the American Institute of Stress (AIS), studies show that job stress has become a leading cause of stress among adults, intensifying over the past decade.

Segment Covered in the Acute Agitation and Aggression Treatment Market:

By Drug Class: Anti-Psychotics, Benzodiazepines, Others.

By Route of Administration: Oral, Intramuscular, Others.

By End Users: Hospitals & Ambulatory Surgical Centers, Psychiatric Care Facilities, Others.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/acute-agitation-and-aggression-treatment-market

Key players involved in Acute Agitation and Aggression Treatment Market:

• Bristol-Myers Squibb Company
• Eli Lilly and Company
• GlaxoSmithKline plc
• H. Lundbeck A/S
• Janssen Biotech, Inc. (Johnson & Johnson)
• Ono Pharmaceutical Co., Ltd.
• Otsuka Holdings Co., Ltd.
• Pfizer Inc.
• Mylan NV
• Teva Pharmaceutical Industries Ltd

*Note:

• Additionally, I wanted to highlight that the full version of the report includes an in-depth analysis of emerging players and startups, which will provide valuable insights into the evolving market landscape and key strategies being adopted.

Regional Analysis:

The Acute Agitation and Aggression Treatment Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Acute Agitation and Aggression Treatment Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.

Related Reports:

Mobile Health Market: https://www.datamintelligence.com/research-report/mobile-health-mhealth-market

Healthcare Analytics Market: https://www.datamintelligence.com/research-report/healthcare-analytics-market

Bioinformatics Market: https://www.datamintelligence.com/research-report/bioinformatics-market

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.